1. Home
  2. GBIO vs NTWK Comparison

GBIO vs NTWK Comparison

Compare GBIO & NTWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • NTWK
  • Stock Information
  • Founded
  • GBIO 2016
  • NTWK 1997
  • Country
  • GBIO United States
  • NTWK United States
  • Employees
  • GBIO N/A
  • NTWK N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • NTWK Computer Software: Prepackaged Software
  • Sector
  • GBIO Health Care
  • NTWK Technology
  • Exchange
  • GBIO Nasdaq
  • NTWK Nasdaq
  • Market Cap
  • GBIO 29.2M
  • NTWK 33.8M
  • IPO Year
  • GBIO 2020
  • NTWK 1998
  • Fundamental
  • Price
  • GBIO $0.38
  • NTWK $2.87
  • Analyst Decision
  • GBIO Strong Buy
  • NTWK
  • Analyst Count
  • GBIO 4
  • NTWK 0
  • Target Price
  • GBIO $7.33
  • NTWK N/A
  • AVG Volume (30 Days)
  • GBIO 558.2K
  • NTWK 12.1K
  • Earning Date
  • GBIO 08-06-2025
  • NTWK 05-14-2025
  • Dividend Yield
  • GBIO N/A
  • NTWK N/A
  • EPS Growth
  • GBIO N/A
  • NTWK N/A
  • EPS
  • GBIO N/A
  • NTWK 0.02
  • Revenue
  • GBIO $24,556,000.00
  • NTWK $64,127,568.00
  • Revenue This Year
  • GBIO N/A
  • NTWK N/A
  • Revenue Next Year
  • GBIO N/A
  • NTWK N/A
  • P/E Ratio
  • GBIO N/A
  • NTWK $143.55
  • Revenue Growth
  • GBIO 146.47
  • NTWK 9.18
  • 52 Week Low
  • GBIO $0.32
  • NTWK $2.14
  • 52 Week High
  • GBIO $3.65
  • NTWK $3.34
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 48.07
  • NTWK 54.66
  • Support Level
  • GBIO $0.35
  • NTWK $2.80
  • Resistance Level
  • GBIO $0.41
  • NTWK $2.91
  • Average True Range (ATR)
  • GBIO 0.03
  • NTWK 0.07
  • MACD
  • GBIO -0.00
  • NTWK -0.02
  • Stochastic Oscillator
  • GBIO 30.11
  • NTWK 25.56

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About NTWK NetSol Technologies Inc. Common Stock

NETSOL Technologies Inc is involved in providing information technology and enterprise software solutions. Its products and services include NFS Ascent, NFS Digital, Leasepak Cloud, Business consultancy, and information security services among others. The firm has North America, Europe, and Asia-Pacific segments, of which the majority of the revenue is derived from Asia-Pacific. It derives revenue from licensing, customization, enhancements, and maintenance of its financial applications. The company promotes and sells its products under the Netsol financial suite.

Share on Social Networks: